Literature DB >> 14452177

Progesterone in the treatment of advanced malignant tumours of breast, ovary and uterus.

B JOLLES.   

Abstract

Entities:  

Keywords:  BREAST NEOPLASMS/therapy; OVARY/neoplasms; PROGESTERONE/therapy; UTERUS NEOPLASMS/therapy

Mesh：

Substances：

Year:  1962        PMID： 14452177      PMCID： PMC2070932          DOI： 10.1038/bjc.1962.24

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  12 in total

1.  A new progeshational steroid in the therapy of endometrial carcinoma--a preliminary report.

Authors:  B A STOLL
Journal:  Cancer Chemother Rep       Date:  1961-10

2.  Progestational agents in the treatment of carcinoma of the endometrium.

Authors:  R M KELLEY; W H BAKER
Journal:  N Engl J Med       Date:  1961-02-02       Impact factor: 91.245

3.  Studies with 19-norethisterone oenanthate in mammary carcinoma.

Authors:  M DOUGLAS; J A LORAINE; J A STRONG
Journal:  Proc R Soc Med       Date:  1960-06

4.  An endocrine basis for endometrial carcinoma.

Authors:  A I SHERMAN; R B WOOLF
Journal:  Am J Obstet Gynecol       Date:  1959-02       Impact factor: 8.661

5.  The use of newer progestins in the treatment of endometriosis.

Authors:  R W KISTNER
Journal:  Am J Obstet Gynecol       Date:  1958-02       Impact factor: 8.661

6.  Experimental maturation or ageing of collagen in rabbits' ears.

Authors:  B JOLLES; S G GREENING; G B DUN
Journal:  Nature       Date:  1956-07-21       Impact factor: 49.962

7.  [Retard effect of gestagens].

Authors:  K JUNKMANN
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1954

8.  Histologic changes in the skin of the female guinea pig following percutaneous application of estrogen.

Authors:  E C PLISKE
Journal:  Anat Rec       Date:  1953-04

9.  Hormonal therapy in cancer of the breast. III. Effect of progesterone on clinical course and hormonal excretion.

Authors:  D GORDON; B N HORWITT; A SEGALOFF; P J MURISON; J V SCHLOSSER
Journal:  Cancer       Date:  1952-03       Impact factor: 6.860

10.  Objective remission of metastatic breast carcinoma in a male who recieved 17-alpha hydroxy progesterone caproate (delalutin).

Authors:  J GELLER; H VOLK; M LEWIN
Journal:  Cancer Chemother Rep       Date:  1961-10
View more
  6 in total

1.  Loss of progesterone receptor through epigenetic regulation is associated with poor prognosis in solid tumors.

Authors:  Yiyang Li; Cheng Huang; Tamar Kavlashvili; Abby Fronk; Yuping Zhang; Yang Wei; Donghai Dai; Eric J Devor; Xiangbing Meng; Kristina W Thiel; Kimberly K Leslie; Shujie Yang
Journal:  Am J Cancer Res       Date:  2020-06-01       Impact factor: 6.166

2.  [Hormonally treated corpus carcinoma and its in vitro metabolism of glucose].

Authors:  H Hackl
Journal:  Arch Gynakol       Date:  1968

3.  Progestin therapy of breast cancer: comparison of agents.

Authors:  B A Stoll
Journal:  Br Med J       Date:  1967-08-05

Review 4.  Current status of the management of patients with endocrine-sensitive tumors. II. Carcinoma of the prostate, endometrium, thyroid, kidney and miscellaneous tumors.

Authors:  L G Crowley; S A Duwe
Journal:  Calif Med       Date:  1969-02

5.  The effect of oestrogens, testosterone and progesterone on the induction of cervico-vaginal tumours in intact and castrate rats.

Authors:  A Glucksmann; C P Cherry
Journal:  Br J Cancer       Date:  1968-09       Impact factor: 7.640

6.  Granulosa-cell tumours induced in mice by progesterone.

Authors:  A Lipschutz; R Iglesias; V I Panasevich; S Salinas
Journal:  Br J Cancer       Date:  1967-03       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.